Age, years: mean (SD) | 193 | 53 (17) | 53 (15) | |
Male sex: n (%) | 108 | 48 (54) | 60 (58) | 0.66 |
Race: n (%) | | | | |
Latinx | 166 | 72 (81) | 94 (90) | 0.02 |
Caucasian | 13 | 10 (11) | 3 (3) | |
African American | 8 | 6 (7) | 2 (2) | |
Other | 6 | 1 (1) | 5 (5) | |
BMI, kg/m2: mean (SD) | 193 | 33.62 (11) | 32.95 (8.20) | 0.62 |
<30 | 86 | 39 (44%) | 47 (45%) | 0.84 |
≥30 | 107 | 50 (56%) | 57 (55%) | |
Serum creatinine: mean (SD) | 193 | 0.73 (0.20) | 0.73 (0.18) | 0.80 |
Signs and symptoms: n (%) | | | |
Fever (subjective) | 143 | 59 (66) | 84 (81) | 0.02 |
Dyspnea | 160 | 65 (73) | 95 (91) | 0.001 |
Cough | 150 | 61 (69) | 89 (86) | 0.005 |
Diarrhea | 40 | 21 (24) | 19 (18) | 0.36 |
Anosmia | 8 | 6 (7) | 2 (2) | 0.14 |
Dysgeusia | 16 | 11 (12) | 5 (5) | 0.06 |
Comorbidities: n (%) | | | |
Diabetes mellitus | 86 | 42 (47) | 44 (42) | 0.50 |
Hypertension | 85 | 40 (45) | 45 (43) | 0.82 |
Cardiac disease | 26 | 12 (13) | 14 (13) | 0.99 |
Respiratory disease | 17 | 8 (9) | 9 (9) | 0.93 |
Liver disease | 9 | 6 (7) | 3 (3) | 0.21 |
Malignancy | 19 | 9 (10) | 10 (10) | 0.91 |
Immunosuppression | 8 | 5 (6) | 3 (3) | 0.34 |
Dyslipidemia | 34 | 16 (18) | 18 (17) | 0.90 |
Vital signs: mean (SD) at presentation | | |
Temperature | 193 | 38.02 (0.92) | 38.38 (0.88) | 0.001 |
Oxygen saturation % | 193 | 86.5% (13%) | 80% (14%) | 0.001 |
APACHE II score | 60 | 13.91 (5.35) | 16.85 (6.35) | 0.15 |
Inflammatory markers: mean (SD) | | |
CRP | 173 | 11.48 (8.02) | 15.57 (9.20) | 0.002 |
ESR | 171 | 57.06 (29.97) | 76.60 (24.20) | <0.0001 |
Ferritin | 165 | 499.14 (435) | 1094.27 (1149) | <0.0001 |
D-dimer | 153 | 1395.43 (1239) | 2075.78 (1586) | 0.005 |
LDH | 160 | 365.64 (303) | 470.77 (227) | 0.01 |
Procalcitonin | 175 | 0.38 (1.38) | 1.80 (7) | 0.06 |